Swiss company, Sandoz announced a $170 million purchase agreement to acquire Cimerli, eye biosimilar medication.
Tag:
Novartis
-
-
Industry & TradeTech/AI
Novartis: it’s ‘too soon’ to know whether malaria drug could be coronavirus vaccine
Swiss pharma giant Novartis on Friday has cautioned that it is “too soon” to be sure whether …
-
Industry & Trade
Novartis boosts Q3 profit, pushes Alcon decision to 2019
by Yomna Yasserby Yomna YasserNovartis’s third-quarter core net income surged 4 percent at constant currencies, beating expectations, as the drugmaker said …
-
Stock markets in Europe opened higher on Wednesday as the earnings season continues. The pan-European Stoxx 600 …
-
European stocks traded higher morning Tuesday with corporate earnings dominating market moves. The pan-European Stoxx 600 was …
-
Industry & Trade
Novartis splits drugs business into two, pharma chief to leave
by Noha Gadby Noha GadNovartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second …
-
European stock-index futures advanced, indicating equities may snap two days of losses, as China’s industrial output growth unexpectedly …
-
European stock markets inched lower on Monday as investors were closely monitoring euro-zone events ahead of a …